Sihuan Pharmaceutical Holdings Group Ltd. 0460

Sihuan Pharmaceutical Holdings Group (SEHK:460) issued new earnings guidance for the first half of 2026, indicating a significant increase in net profit on stable revenue, supported by medical aesthetics, drug commercialization, associate profits and asset divestments. See our latest analysis for Sihuan Pharmaceutical Holdings Group. Sihuan Pharmaceutical Holdings Group’s recent earnings guidance comes after a mixed period for investors. The share price is at HK$0.905, with a 90 day share...